Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study (International Journal of Clinical Oncology, (2022), 27, 12, (1828-1838), 10.1007/s10147-022-02232-7)

Shunichi Sugawara; Masashi Kondo; Toshihide Yokoyama; Toru Kumagai; Makoto Nishio; Koichi Goto; Kazuhiko Nakagawa; Takashi Seto; Nobuyuki Yamamoto; Kentarou Kudou; Takayuki Asato; Pingkuan Zhang; Yuichiro Ohe

doi:10.1007/s10147-022-02252-3

Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study (International Journal of Clinical Oncology, (2022), 27, 12, (1828-1838), 10.1007/s10147-022-02232-7)

Shunichi Sugawara, Masashi Kondo, Toshihide Yokoyama, Toru Kumagai, Makoto Nishio, Koichi Goto, Kazuhiko Nakagawa, Takashi Seto, Nobuyuki Yamamoto, Kentarou Kudou, Takayuki Asato, Pingkuan Zhang, Yuichiro Ohe

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

抄録

In the original publication in Table 1, the entry: “Nichirei Histofine RALK iAEP Kit” should read as: “Nichirei Histofine ALK iAEP Kit”. The correct version of Table 1 is given in this correction. The original publication has been corrected.

本文言語	英語
ページ（範囲）	1839-1840
ページ数	2
ジャーナル	International Journal of Clinical Oncology
巻	27
号	12
DOI	https://doi.org/10.1007/s10147-022-02252-3
出版ステータス	出版済み - 12-2022
外部発表	はい

All Science Journal Classification (ASJC) codes

外科
血液学
腫瘍学

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1007/s10147-022-02252-3

他のファイルとリンク

フィンガープリント

「Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study (International Journal of Clinical Oncology, (2022), 27, 12, (1828-1838), 10.1007/s10147-022-02232-7)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル

Sugawara, S., Kondo, M., Yokoyama, T., Kumagai, T., Nishio, M., Goto, K., Nakagawa, K., Seto, T., Yamamoto, N., Kudou, K., Asato, T., Zhang, P., & Ohe, Y. (2022). Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study (International Journal of Clinical Oncology, (2022), 27, 12, (1828-1838), 10.1007/s10147-022-02232-7). International Journal of Clinical Oncology, 27(12), 1839-1840. https://doi.org/10.1007/s10147-022-02252-3

Sugawara, Shunichi ; Kondo, Masashi ; Yokoyama, Toshihide その他. / Correction to : Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study (International Journal of Clinical Oncology, (2022), 27, 12, (1828-1838), 10.1007/s10147-022-02232-7). In: International Journal of Clinical Oncology. 2022 ; Vol. 27, No. 12. pp. 1839-1840.

@article{f75990035652409697ac16609d820d75,

title = "Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study (International Journal of Clinical Oncology, (2022), 27, 12, (1828-1838), 10.1007/s10147-022-02232-7)",

abstract = "In the original publication in Table 1, the entry: “Nichirei Histofine RALK iAEP Kit” should read as: “Nichirei Histofine ALK iAEP Kit”. The correct version of Table 1 is given in this correction. The original publication has been corrected.",

author = "Shunichi Sugawara and Masashi Kondo and Toshihide Yokoyama and Toru Kumagai and Makoto Nishio and Koichi Goto and Kazuhiko Nakagawa and Takashi Seto and Nobuyuki Yamamoto and Kentarou Kudou and Takayuki Asato and Pingkuan Zhang and Yuichiro Ohe",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = dec,

doi = "10.1007/s10147-022-02252-3",

language = "English",

volume = "27",

pages = "1839--1840",

journal = "International Journal of Clinical Oncology",

issn = "1341-9625",

publisher = "Springer Japan",

number = "12",

}

Sugawara, S, Kondo, M, Yokoyama, T, Kumagai, T, Nishio, M, Goto, K, Nakagawa, K, Seto, T, Yamamoto, N, Kudou, K, Asato, T, Zhang, P & Ohe, Y 2022, 'Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study (International Journal of Clinical Oncology, (2022), 27, 12, (1828-1838), 10.1007/s10147-022-02232-7)', International Journal of Clinical Oncology, vol. 27, no. 12, pp. 1839-1840. https://doi.org/10.1007/s10147-022-02252-3

Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study (International Journal of Clinical Oncology, (2022), 27, 12, (1828-1838), 10.1007/s10147-022-02232-7). / Sugawara, Shunichi; Kondo, Masashi; Yokoyama, Toshihide その他.
In: International Journal of Clinical Oncology, Vol. 27, No. 12, 12.2022, p. 1839-1840.

研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

TY - JOUR

T1 - Correction to

T2 - Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study (International Journal of Clinical Oncology, (2022), 27, 12, (1828-1838), 10.1007/s10147-022-02232-7)

AU - Sugawara, Shunichi

AU - Kondo, Masashi

AU - Yokoyama, Toshihide

AU - Kumagai, Toru

AU - Nishio, Makoto

AU - Goto, Koichi

AU - Nakagawa, Kazuhiko

AU - Seto, Takashi

AU - Yamamoto, Nobuyuki

AU - Kudou, Kentarou

AU - Asato, Takayuki

AU - Zhang, Pingkuan

AU - Ohe, Yuichiro

PY - 2022/12

Y1 - 2022/12

N2 - In the original publication in Table 1, the entry: “Nichirei Histofine RALK iAEP Kit” should read as: “Nichirei Histofine ALK iAEP Kit”. The correct version of Table 1 is given in this correction. The original publication has been corrected.

AB - In the original publication in Table 1, the entry: “Nichirei Histofine RALK iAEP Kit” should read as: “Nichirei Histofine ALK iAEP Kit”. The correct version of Table 1 is given in this correction. The original publication has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85139928924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85139928924&partnerID=8YFLogxK

U2 - 10.1007/s10147-022-02252-3

DO - 10.1007/s10147-022-02252-3

M3 - Comment/debate

C2 - 36243793

AN - SCOPUS:85139928924

SN - 1341-9625

VL - 27

SP - 1839

EP - 1840

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

IS - 12

ER -

Sugawara S, Kondo M, Yokoyama T, Kumagai T, Nishio M, Goto K その他. Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study (International Journal of Clinical Oncology, (2022), 27, 12, (1828-1838), 10.1007/s10147-022-02232-7). International Journal of Clinical Oncology. 2022 12月;27(12):1839-1840. doi: 10.1007/s10147-022-02252-3